Showing results (41-50 of 395) with videos related to

Sort By:
Pageof 40
Brain Pathology (Zurich, Switzerland)|January 30, 2013
Miniaturized handheld confocal microscopy identifies focal brain invasion in a mouse model of aggressive meningiomaMatthieu Peyre, Estelle Clermont-Taranchon, Anat Stemmer-Rachamimov, et al.
Neuropathology and Applied Neurobiology|September 30, 2025
A Specific Methylation Class Identifies BAP1-Deficient Meningiomas, Including Meningeal Tumours With Poorly Differentiated Nonrhabdoid HistologyPhilippe Drabent, Mehdi Touat, Patrick R Benusiglio, et al.
American Journal of Medical Genetics. Part A|January 17, 2013
Neurofibromatosis type 2 in the elderly population: clinical and molecular featuresStéphane Goutagny, Alpha B Bah, Béatrice Parfait, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2016
Mechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2Aziz Ouerdani, Stéphane Goutagny, Michel Kalamarides, et al.
Neurosurgical Review|June 15, 2011
Posterior petrous bone meningiomas: surgical experience in 53 patients and literature reviewMatthieu Peyre, Alexis Bozorg-Grayeli, Alain Rey, et al.
Neurosurgery|October 13, 2025
Nodular Growths of NF2-Related Schwannomatosis Vestibular Schwannoma: Clinical and Therapeutical ConsequencesManwi Singh, Louise Deboeuf, Noemi Jester, et al.
Current Opinion in Oncology|January 1, 2005
Molecular changes in gliomasMarc Sanson, Joëlle Thillet, Khê Hoang-Xuan
Current Opinion in Oncology|January 1, 2005
Palliative care in patients with primary brain tumorsSophie Taillibert, Florence Laigle-Donadey, Marc Sanson
Neurosurgery|January 13, 2023
Surgical Management of Peripheral Nerve Pathology in Patients With Neurofibromatosis Type 2Matthieu Peyre, Suzanne Tran, Béatrice Parfait, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|October 14, 2008
Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patientsAlexis Bozorg Grayeli, Michel Kalamarides, Didier Bouccara, et al.
Pageof 40